What is a Vesicant?
A vesicant is a drug or chemical agent that, when accidentally leaked into surrounding tissue (extravasation), has the potential to cause severe tissue damage including blistering, necrosis, and ulceration. 1
Definition and Classification
Vesicants represent the most dangerous category in a three-tier classification system used for drugs based on their tissue damage potential 1:
- Vesicants: Agents capable of causing severe tissue injury, blistering, and necrosis
- Irritants: Agents that cause inflammation and pain but typically not necrosis
- Non-vesicants: Agents that cause minimal to no tissue damage
Clinical Significance in Chemotherapy
In the oncology setting, vesicant chemotherapy agents pose significant risk during intravenous administration. The degree of tissue damage depends on four critical factors: the specific drug type, drug concentration, anatomical location of extravasation, and duration of tissue exposure 1.
Common Vesicant Chemotherapy Agents
The ESMO-EONS guidelines identify key vesicant chemotherapies including 1:
- Anthracyclines (doxorubicin, epirubicin)
- Vinca alkaloids
- Mechlorethamine
- Mitoxantrone (though classification has been debated, case evidence supports vesicant categorization) 2
Clinical Presentation
Early symptoms of vesicant extravasation include tingling, burning sensation, pain, swelling, and redness at the injection site. Later manifestations progress to blistering, tissue necrosis, and ulceration 1. These symptoms may be subtle initially but typically worsen over days to weeks, with inflammation increasing and potentially evolving into frank necrosis 1.
Prevention Requirements
Because vesicants carry such high morbidity risk, specific safety protocols are mandatory 1:
- Never use butterfly needles for vesicant infusions (easily displaced, can puncture venous wall)
- Use flexible cannulae only
- For prolonged infusions (12-24 hours), central venous access is highly recommended
- Avoid high-risk sites: anticubital fossa, dorsum of hand, areas over joints, inner wrist
- Continuous monitoring throughout administration with regular blood return checks
Beyond Chemotherapy
The term "vesicant" also applies to chemical warfare agents (mustard gas, lewisite) that cause similar blistering injuries through different mechanisms 3, 4, 5. Additionally, certain noncytotoxic agents like concentrated electrolyte solutions (10% sodium chloride, 2% calcium chloride) are classified as vesicants based on their tissue injury potential 6, 7.
Critical Management Principle
Only one-third of vesicant extravasations progress to ulceration, but when they do, the consequences can be devastating, often requiring surgical debridement and skin grafting 1. This underscores why prevention through proper technique and early recognition are paramount—the tissue damage from vesicants is often irreversible once established.